News | January 07, 2009

Siteman Cancer Center Adds Second TomoTherapy Hi-Art Treatment System

January 8, 2009 - TomoTherapy Inc. said today that Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO., has commenced treating patients on its second TomoTherapy Hi-Art(R) treatment system.

Siteman, a National Cancer Institute (NCI) Comprehensive Cancer Center, installed its first Hi-Art system in early 2006. The installation of a second unit enables more cancer patients to benefit from this intensity-modulated radiation therapy (IMRT) solution.

"We knew the benefits of arc-based radiation delivery before installing our first TomoTherapy unit,” said Dan Low, Ph.D., associate professor of radiation oncology, Washington University School of Medicine. “Upon installation, we gained the ability to deliver IMRT in a continuous helical pattern, and the infrastructure and workflow to apply image guidance to each treatment, for every patient. This is something we cannot do on any other system. As we've become more accustomed to the benefits of this platform, we saw a need for a second Hi-Art system."

For more information: www.TomoTherapy.com, www.siteman.wustl.edu.

Related Content

Varian Receives FDA 510k Clearance for Halcyon Treatment System
Technology | Intensity Modulated Radiation Therapy (IMRT) | July 05, 2017
Varian Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Halcyon system,...
First New York Metropolitan Hospital Treats Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | July 03, 2017
Accuray Inc. and Montefiore Einstein Center for Cancer Care (MECCC), part of the Montefiore Health System (MHS),...
IUCT Oncopole Installs First Radixact Radiotherapy System in France
News | Intensity Modulated Radiation Therapy (IMRT) | June 20, 2017
Accuray Inc. announced that the University Cancer Institute of Toulouse Oncopole (IUCT Oncopole) in Toulouse, France,...
cervical and endometrial cancer, IMRT, intensity modulated radiation therapy, side effects, ASTRO 2016 study
News | Intensity Modulated Radiation Therapy (IMRT) | September 29, 2016
Patients with cervical and endometrial cancer have fewer gastrointestinal and genitourinary side effects and experience...
non-small cell lung cancer, NSCLC, IMRT, toxicity, intensity modulated radiation therapy, 3-D CRT, ASTRO 2015
News | Lung Cancer | October 28, 2015
October 28, 2015 — An analysis of an international, cooperative-led trial of patients with locally advanced non-small
pediatric ependymoma patients, immediate post-surgical radiation therapy, Children's Oncology Group ACNS0121 trial, ASTRO 2015
News | Radiation Therapy | October 22, 2015
Outcomes for pediatric patients as young as 12 months with ependymoma who are treated with immediate post-operative...
post-prostatectomy IG-IMRT, image-guided intensity-modulated radiation therapy, toxicity, ASTRO, Practical Radiation Oncology
Feature | Intensity Modulated Radiation Therapy (IMRT) | October 06, 2015
A prospective study of guideline-based postoperative image-guided intensity modulated radiation therapy (IG-IMRT) in...
Gustave Roussy, Elekta, Versa HD, linear accelerators, Mosaiq, France

Image courtesy of Elekta

News | Radiation Therapy | September 04, 2015
Gustave Roussy has awarded Elekta with an order for four Versa HD linear accelerators, replacing their existing...
Overlay Init